See also this year's filing and all EDGAR filings for this company.
PDF Report 0001232524_2023_Jazz_Pharmaceuticals_plc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001232524, Jazz Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,606,140,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,487,099,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 742,016,000 |
| 4 | LiabilitiesCurrent | 933,193,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,416,967,000 |
| 9 | ResearchAndDevelopmentExpense | 1,034,601,000 |
| 10 | remainder_Expenses | 1,114,689,000 |
| 11 | remainder_Revenues | 3,659,374,000 |
| 12 | remainder_NetIncome | -317,177,000 |
| 13 | remainder_ComprehensiveNetIncome | -725,149,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,835,255,000 |
| 1 | Liabilities | 933,193,000 |
| 2 | Expenses | 3,566,257,000 |
| 3 | Revenues | 3,659,374,000 |
| 4 | StockholdersEquity | 9,902,062,000 |
| 5 | NetIncome | -224,060,000 |
| 6 | ComprehensiveNetIncome | -586,634,500 |
| 7 | BaseVar | 10,018,202,500 |
| 8 | EconomicCapitalRatio | 2.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
